Hikma Pharmaceutical | HIK - صافي الدخل





صافي الدخل تغيير تاريخ
Almirall EUR 19.58M 7M 2025-12
argenx SE USD 472M 106M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Autolus Therapeutics Ltd USD -90.33M 11.21M 2025-12
Bayer EUR 2.76B 6.52B 2026-03
Fresenius EUR 361M 17M 2025-12
Genmab DKK 31M 370M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GRIFOLS EUR 73M 25.25M 2026-03
Hikma Pharmaceutical USD 164M 45M 2025-12
Lakefront Biotherapeutics EUR 14.49M 767.65M 2026-03
Lonza CHF 426M 119M 2025-06
Merck EUR 659M 340M 2026-03
Orion EUR 140.2M 49.8M 2026-06
Recordati EUR 153.06M 35.75M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 1.61B 2.42B 2026-03
UCB EUR 1.08B 608M 2025-12